Sigma Labs Awarded Contract with Laser Zentrum Nord GmbH For PrintRite 3D® to Certify its IPQA® Methodology for Serial Production

 

 

SANTA FE, N.M. – December 22, 2017 – Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced that it has received a contract from Laser Zentrum Nord (LZN) GmbH, a leading Additive Manufacturing (AM) technology and research innovator located in Hamburg, Germany for PrintRite 3D INSPECT®. Terms of the contract have not been disclosed.

The two companies have also agreed to actively collaborate to certify Sigma’s IPQA® methodology and solutions for serial production 3D printing in the aerospace industry. The PrintRite3D® system will be installed onto a SLM Solutions selective laser melting machine located at Laser Zentrum Nord GmbH in Hamburg, Germany.

“Advancements of 3D metal printing into production have been hampered by the inability to identify, monitor and mitigate defects during the printing process,” said John Rice, Chief Executive Officer of Sigma Labs. “We’re excited to work with Laser Zentrum Nord GmbH on the in-process dynamic behaviors that cause defects and to demonstrate and document how our PrintRite3D IPQA® software addresses and solve these problems. This contract further validates Sigma Labs’ position as a leader in third party, platform independent quality assurance for the metal additive manufacturing industry.”

This instillation will add an additional machine platform to Sigma Labs’ successes for the deployment of Sigma Labs’ PrintRite 3D® quality assurance technology.

About Sigma Labs
Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at www.sigmalabsinc.com.

About Laser Zentrum Nord GmbH
The Laser Zentrum Nord GmbH, founded in 2009, pursues the goal of decisively promoting knowledge and technology transfer from basic research to industrial application. Their objective is to decisively improve, facilitate and accelerate the transfer of knowledge and technology from basic research to industrial application. The LZN serves as a link between basic research and application in an effort to strengthen company’s completive position within their respective industries.

Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on March 31, 2017 and which may be viewed at http://www.sec.gov.

Investor Relations Contact:
Bret Shapiro
Managing Director
CORE IR
561-479-8566
brets@coreir.com

Source: Sigma Labs, Inc.

Add a Comment

Your email address will not be published. Required fields are marked *

+

KFi3

Please type the text above:

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>